-
Mashup Score: 1
Last year, a presentation at the American College of Rheumatology Convergence provided a glimpse into a potential mechanism of inflammation in rheumatoid arthritis that may fundamentally alter treatment approaches. Cornelia M. Weyand, MD, PhD, a professor of medicine and immunology at the Mayo Clinic College of Medicine and Science, and professor emerita of medicine at the Stanford
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5
DESTIN, Fla. — Pinpointing rare subtypes of Ehlers-Danlos syndrome is crucial, as the consequences of overlooking them could be deadly, according to a speaker at the Congress of Clinical Rheumatology East.“It is important to identify these few people because some of these diseases are actually life-threatening,” Anne-Marie Malfait, MD, PhD, professor of medicine at Rush Medical
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4‘Be aggressive’ in detecting, managing interstitial lung disease in early scleroderma - 3 day(s) ago
DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and aggressive action, according to data presented at the Congress of Clinical Rheumatology East.“Most of us really try to be more conservative in scleroderma,” Dinesh Khanna, MD, MSc, a professor of medicine at the University of Michigan Medical Cener, told attendees.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2
DESTIN, Fla. — Clinical practice guidelines for chronic pain sometimes emerge through flawed processes, present conflicting statements, and warrant close evaluation, according to a speaker at the Congress of Clinical Rheumatology East.“Clinical practice guidelines on chronic pain, on the same topic, unfortunately, provide conflicting recommendations,” Jason W. Busse, DC, PhD, a
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5
DESTIN, Fla. — Physicians can consider cannabis before opioids for chronic pain when other options have been exhausted, according to a speaker at the Congress of Clinical Rheumatology East.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2
DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame of mind, according to a speaker at the Congress of Clinical Rheumatology East.“Understand your patient’s mindset before making a recommendation,” E. Michael Lewiecki, MD, clinical professor of medicine at the University of New Mexico Health Sciences Center,
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
DESTIN, Fla. — When choosing between biologic drugs for systemic lupus erythematosus, it is important to know the “ideal patient profile” each is best suited for, according to a speaker at the Congress of Clinical Rheumatology East. Ronald van Vollenhoven, MD, PhD, of the Amsterdam University Medical Center, in the Netherlands, told attendees how they can “choose
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2Osteoarthritis may be 'inherently' tied to neuroplasticity - 6 day(s) ago
DESTIN, Fla. — “Sprouting” of new nerve endings in certain areas of the knee could be a key to understanding osteoarthritis and developing new treatments, according to a speaker at the Congress of Clinical Rheumatology East.“Neuroplasticity is a new finding in the disease that might be, inherently, the disease,” Ann-Marie Malfait, MD, PhD, professor of medicine at
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 10
DESTIN, Fla. — The 2022 American College of Rheumatology recommendations on integrative therapy in rheumatoid arthritis can help make sense of “messy” data on diet and other wellness behaviors, according to a speaker.“For a while we could be monocentric about RA treatment guidelines,” Bryant England, MD, PhD, an associate professor in the division of rheumatology and
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2
DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed by an antiresorptive agent, according to a speaker at the Congress of Clinical Rheumatology East.“Osteoporosis has been called a silent disease,” E. Michael Lewiecki, MD, clinical professor of medicine at the University of New Mexico Health Sciences Center, and
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
👁️🗨️ “If we want to turn RA into a curable disease, we need to repair the immune system before the patient ever gets sick. Can we repair the mitochondria?” Cornelia Weyand @MayoClinic @Stanford 🔬👩🔬 Read more @HealioRheum ⬇️ https://t.co/Jut87Ov2uG